health outcomes

The Importance of Continuous Iteration in Health Equity Plans for REACH ACOs

Next year REACH ACOs will have to show success in developing and maintaining comprehensive health equity plans, and by kicking the can down the road they risk not knowing enough about their patient population in terms of what works better and what doesn't. ACOs can pay in the effort of continuous iteration now or they can pay in poor health outcomes for their patients and the resulting increased costs. The choice is theirs, but one they each have to make.

By Hillit Meidar-Alfi

Health Tech, Payers

Signify Health Teams Up with Cardinal Health for In-home Medication Management

Through the partnership, Signify Health clinicians will be able to use Cardinal's OutcomesOne platform and perform an in-home, CMS-compliant medication review to determine which members are not taking their medications as prescribed and address those needs.

By Marissa Plescia

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

Health Tech, Hospitals

Socially Determined unveils metric measuring impact of social connectedness on health outcomes, business performance

The metric analyzes the influences of loneliness, social network quality, social capital and other data to deliver insights into how those factors converge to impact a community and the people living there, according to the company.

By Michael Schroeder

Payers, Hospitals

Intermountain, UnitedHealthcare create ACO for Medicare Advantage members

The health system and payer will coordinate care for eligible Medicare Advantage patients through the ACO, with the aim of improving health outcomes and reducing costs. The ACO expands a long-standing relationship between the two entities.

By Anuja Vaidya

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.